Prognostic Analyses on a Validation Series of Patients with Waldenström's Disease

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

June 15, 2030

Study Completion Date

June 15, 2030

Conditions
Waldenstrom's DiseasePrognostic Index
Trial Locations (15)

31059

NOT_YET_RECRUITING

Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse

33076

NOT_YET_RECRUITING

Institut Bergonie, Bordeaux

33505

NOT_YET_RECRUITING

LIBOURNE - Hôpital Robert Boulin, Libourne

49933

NOT_YET_RECRUITING

Angers Chu, Angers

51092

NOT_YET_RECRUITING

Reims Chu, Reims

59000

RECRUITING

LILLE GHICL - Hôpital Saint Vincent de Paul, Lille

62300

NOT_YET_RECRUITING

LENS - GHT Artois, Lens

63000

NOT_YET_RECRUITING

Clermont-Ferrand - Chu Estaing, Clermont-Ferrand

67033

NOT_YET_RECRUITING

Strasbourg - Icans, Strasbourg

75651

NOT_YET_RECRUITING

APHP - Hôpital Pitié Salpêtrière - Hématologie, Paris

80054

NOT_YET_RECRUITING

AMIENS - CH Amiens Picardie Site Sud, Amiens

86021

NOT_YET_RECRUITING

POITIERS - Hématologie et Thérapie Cellulaire, Poitiers

130009

NOT_YET_RECRUITING

Institut Paoli Calmette, Marseille

Unknown

NOT_YET_RECRUITING

Le Mans CH, Le Mans

NOT_YET_RECRUITING

VERSAILLES - Hôpital André Mignot, Versailles

All Listed Sponsors
lead

French Innovative Leukemia Organisation

OTHER